A naukri.com initiative
Hitconsultant
3w
39
Image Credit: Hitconsultant
ForSight Robotics Raises $125M for Ophthalmic Robotic Surgery
- ForSight Robotics, a pioneer in ophthalmic robotic surgery, secures a $125M Series B round led by Eclipse to advance the ORYOM Platform for cataract and other eye diseases.
- The funding round brings ForSight Robotics' total funding to $195M and includes participation from a strategic investor, Dr. Fred Moll, the Adani Group, Reiya Ventures, and other existing investors.
- The global vision crisis, with over one billion people suffering from preventable vision impairment and a projected decline in ophthalmologists, highlights the need for advancements in eye surgery.
- ForSight Robotics aims to enhance surgical precision and increase patient access to high-quality treatment, especially for cataracts where millions globally lack adequate surgical care.
- Dr. Joseph Nathan sees ophthalmology as the next frontier in robotics, offering immense opportunities to address global eye care needs similar to the impact of robotics in general surgery.
- The ORYOM Platform, designed for precise ophthalmic procedures, combines AI-based algorithms, advanced computer vision, and micromechanics to enable enhanced surgical capabilities and better ergonomic experience for surgeons.
- ForSight Robotics has achieved milestones such as doubling its employee size, obtaining ISO certification, and completing successful procedures on animal eye models with the ORYOM Platform, setting the stage for upcoming clinical trials in robotic cataract surgery.
Read Full Article
2 Likes
For uninterrupted reading, download the app